PMID- 12210835 OWN - NLM STAT- MEDLINE DCOM- 20021115 LR - 20071114 IS - 0360-4012 (Print) IS - 0360-4012 (Linking) VI - 69 IP - 5 DP - 2002 Sep 1 TI - Human bone marrow stromal cell cultures conditioned by traumatic brain tissue extracts: growth factor production. PG - 687-91 AB - Treatment of traumatic brain injury (TBI) with bone marrow stromal cells (MSCs) improves functional outcome in the rat. However, the specific mechanisms by which introduced MSCs provide benefit remain to be elucidated. Currently, the ability of therapeutically transplanted MSCs to replace injured parenchymal CNS tissue appears limited at best. Tissue replacement, however, is not the only possible compensatory avenue in cell transplantation therapy. Various growth factors have been shown to mediate the repair and replacement of damaged tissue, so trophic support provided by transplanted MSCs may play a role in the treatment of damaged tissue. We therefore investigated the temporal profile of various growth factors, brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), and hepatocyte growth factor (HGF), within cultures of human MSCs (hMSCs) conditioned with cerebral tissue extract from TBI. hMSCs were cultured with TBI extracts of rat brain in vitro and quantitative sandwich enzyme-linked immunosorbent assays (ELISAs) were performed. TBI-conditioned hMSCs cultures demonstrated a time-dependent increase of BDNF, NGF, VEGF, and HGF, indicating a responsive production of these growth factors by the hMSCs. The ELISA data suggest that transplanted hMSCs may provide therapeutic benefit via a responsive secretion of an array of growth factors that can foster neuroprotection and angiogenesis. CI - Copyright 2002 Wiley-Liss, Inc. FAU - Chen, Xiaoguang AU - Chen X AD - Department of Neurology, Henry Ford Health Sciences Center, Detroit, Michigan 48202, USA. FAU - Katakowski, Mark AU - Katakowski M FAU - Li, Yi AU - Li Y FAU - Lu, Dunyue AU - Lu D FAU - Wang, Lei AU - Wang L FAU - Zhang, Lijie AU - Zhang L FAU - Chen, Jieli AU - Chen J FAU - Xu, Yongxian AU - Xu Y FAU - Gautam, Subhash AU - Gautam S FAU - Mahmood, Asim AU - Mahmood A FAU - Chopp, Michael AU - Chopp M LA - eng GR - P01 NS23393/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Neurosci Res JT - Journal of neuroscience research JID - 7600111 RN - 0 (Brain-Derived Neurotrophic Factor) RN - 0 (Endothelial Growth Factors) RN - 0 (Growth Substances) RN - 0 (Intercellular Signaling Peptides and Proteins) RN - 0 (Lymphokines) RN - 0 (Tissue Extracts) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (Vascular Endothelial Growth Factors) RN - 103107-01-3 (Fibroblast Growth Factor 2) RN - 67256-21-7 (Hepatocyte Growth Factor) RN - 9061-61-4 (Nerve Growth Factor) SB - IM MH - Analysis of Variance MH - Animals MH - Bone Marrow Cells/*drug effects/metabolism MH - Brain Chemistry MH - Brain Injuries/pathology MH - Brain-Derived Neurotrophic Factor/biosynthesis MH - Endothelial Growth Factors/biosynthesis MH - Enzyme-Linked Immunosorbent Assay MH - Fibroblast Growth Factor 2/biosynthesis MH - Growth Substances/*biosynthesis MH - Hepatocyte Growth Factor/biosynthesis MH - Humans MH - Intercellular Signaling Peptides and Proteins/biosynthesis MH - Lymphokines/biosynthesis MH - Male MH - Nerve Growth Factor/biosynthesis MH - Rats MH - Rats, Wistar MH - Stromal Cells/*drug effects/metabolism MH - Tissue Extracts/chemistry/*pharmacology MH - Vascular Endothelial Growth Factor A MH - Vascular Endothelial Growth Factors EDAT- 2002/09/05 10:00 MHDA- 2002/11/26 04:00 CRDT- 2002/09/05 10:00 PHST- 2002/09/05 10:00 [pubmed] PHST- 2002/11/26 04:00 [medline] PHST- 2002/09/05 10:00 [entrez] AID - 10.1002/jnr.10334 [doi] PST - ppublish SO - J Neurosci Res. 2002 Sep 1;69(5):687-91. doi: 10.1002/jnr.10334.